Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01100658. We help you review the study, but cannot decide medical eligibility.
TerminatedNCT01100658
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
A short description of this study’s research objective has not yet been verified.
Medication studyAges 8–17United StatesADHD
Understand this study
Who could participate?
Listed age limits: 8 years to 17 years.
- Listed locations
- Minneapolis, United StatesSee all locations and recruitment
- Activities
- Medication described in the protocol · Placebo comparator
- Compensation
- Payment and expense reimbursement have not been verified.
Registry last updated: · Record retrieved: . These dates do not confirm site availability.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMay 2010
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 1
- Sponsor
- University of Minnesota
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 8 Years to 17 Years
- Official registry ID
- NCT01100658
- Official title
- Effects of Methylphenidate on Neuropsychological Functioning in Children With Attention Deficits Secondary to Childhood Cancer
Recruitment & locations
TerminatedMinneapolis
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University of Minnesota, a university.
Does this study involve medication?
Yes. The study involves medication, including Methylphenidate and Placebo.
Who can participate?
Listed age limits: 8 years to 17 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
TerminatedNCT01721330
A Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
This study was terminated in the United States. It focuses on ADHD.
TerminatedNCT06673368
Parallel, Adaptive-Design, study Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
This study was terminated in the United States. It focuses on ADHD.
TerminatedNCT00554385
A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has public registry information. It focuses on ADHD and currently lists study information in the United States.